Skip to main content
DAVITA INC. logo

DAVITA INC. — Investor Relations & Filings

Ticker · DVA ISIN · US23918K1088 LEI · M2XHYMU3TZNEZURC6H66 US Human health and social work activities
Open in API
Filings indexed 2,061 across all filing types
Latest filing 2020-09-09 Director's Dealing
Country US United States of America
Listing US DVA

About DAVITA INC.

https://www.davita.com/

DaVita Inc. is a healthcare provider specializing in kidney care services. The company offers a range of treatments for patients with chronic kidney disease and end-stage kidney disease, primarily through a network of outpatient dialysis centers. Its core service is providing life-sustaining dialysis, including in-center hemodialysis and peritoneal dialysis. In addition to clinical treatments, DaVita provides integrated health care management and extensive patient support. This includes educational resources, tools, and dietary guidance to help individuals manage their kidney health throughout their entire disease journey. The company focuses on delivering holistic and equitable care to improve the quality of life for its patients.

Recent filings

Filing Released Lang Actions
FORM 3
Director's Dealing
2020-09-09 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated September 7, 2020, reporting the appointment of a new director to the Board of Directors and changes in the Board size. The key section is Item 5.02, which relates to the departure or appointment of directors or officers. There is no financial data or report content, only an announcement of management changes. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 3845 characters, which is relatively short and consistent with a management change announcement rather than a full report. Therefore, the correct classification is MANG with high confidence.
2020-09-08 English
SC TO-I/A Filing
Regulatory Filings
2020-09-08 English
M&A Activity 2020
M&A Activity Classification · 95% confidence The document is a letter from Sidley Austin LLP to the SEC Division of Corporation Finance responding to comments on a Schedule TO-I filed by DaVita Inc. The Schedule TO-I relates to a tender offer, specifically a modified Dutch auction for repurchasing shares. The letter addresses SEC staff comments and the company's planned amendments to the Schedule TO-I and related Offer to Purchase documents. The presence of Schedule TO-I and references to tender offer rules (Rule 13e-4) and amendments to the Offer to Purchase clearly indicate this is related to a tender offer transaction filing. This is not a full report like an Annual Report or Earnings Release, nor is it a proxy or voting result. It is a regulatory correspondence related to a tender offer filing. The best matching category is M&A Activity (Code: TAR), which covers announcements and documents related to merger proposals or takeover bids, including tender offers and Schedule TO filings. The document length is substantial and contains detailed responses, not just a brief announcement or certification, so it is not RNS or RPA. Therefore, the classification is TAR with high confidence.
2020-08-27 English
SC TO-I/A Filing
Regulatory Filings
2020-08-27 English
FORM 4
Director's Dealing
2020-08-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.